---
category: news
title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
excerpt: "Initial program to focus on development of a companion diagnostic for HiberCellâ€™s novel immunotherapy, Imprime PGG, to aid in patient selection across multiple oncology programs Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell,"
publishedDateTime: 2021-01-13T12:25:00Z
originalUrl: "https://www.morningstar.com/news/business-wire/20210113005304/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization"
webUrl: "https://www.morningstar.com/news/business-wire/20210113005304/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Morningstar, Inc.
  domain: morningstar.com

topics:
  - AI in Healthcare
  - AI

secured: "0XKmngo7MRSwLlK7YstsJR/uNZmyJALVMYCAMTHMFPlS8uXN5GP00OpODrYgrxzjODxxCx8Q8QsstHz1SyKbEOWKqOKxNBS3itWSomm4lxa+BL0TmmSsTu9ForSchhpgAp8NsEH6FzhmHeVgjkw9U8MQ/LdAc2HZzXBHxjdWQR7etwU+RPZCtylQGG+UZLubgGscxoNGci2xJE2h+SF8V7cAH8NotIkzCRrBapb3/9Z1ZiYTRRdUMP83rO1gbgYc8cHQMGe3nWKAM29fnL5RyACPTnk0uvWZHZlrMnw5sGSzlJNybz0pGzYAeYVT+6h0TbssCkg+ybxyVhu5zzqv2L8I4U700WscNpk5Cni8UgU=;6QaOah4syguV2rBJMVGI1A=="
---

